Indocyanine Green Clearance Test in Liver Transplantation (LivInG)
Status:
Not yet recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
The gap between patients awaiting and those undergoing liver transplantation (LT) continues
to grow. Marginal organs carry higher risk of failure after LT however they are increasingly
used to fill such gap. Viability assessment of the graft is essential to lower the risk of LT
failure and need for emergency re-LT, however this still relies mainly on surgeon's
experience. Post-LT graft function recovery assessment is also essential to aid physicians in
the management of LT recipients and guide them through challenging decision-making.
With the present study we aim to validate the use of indocyanine green clearance test (IGT)
in two settings: in the donor as an objective tool to assess graft viability; in the
recipient to assess graft function recovery after LT.
The implementation of IGT in routine practice translates into two main advantages: to avoid
using grafts with no chance of recovery and to optimize resource allocation to LT recipients
depending on their graft function recovery.